With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost o...

Accredo employs more than 800 specialty pharmacists who are dedicated to educating and assisting patients with rare or complex conditions.

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...

Accredo, which is Evernorth’s industry-leading specialty pharmacy, offers decades of condition-specific expertise, a full breadth of clinical support, and a wide variety of patient services.

In this episode of the Health Unscripted Podcast, Matt Perlberg, president of the Evernorth Health Services pharmacy businesses, sits down with Vicki Wheeler, chief operating officer of Evernorth's ph...

Learn how adherence-focused specialty pharmacy care models reduce avoidable costs and improve outcomes in inflammatory care.

At Accredo by Evernorth, we’re witnessing a transformation in neurological care as innovative treatments move from research to reality.

Accredo has been helping patients access copay assistance programs for more than 10 years. Learn how copay assistance programs help patients access the care they need.